ArticleClinical pharmacology and therapeutics2012

Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers.

K E Dooley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.